Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064

Abstract

In the original publication, there was an inadvertent labeling mistake in Figure 11A as published [...].

Figure 11

Photomicrographs of microsections of the pancreas of rats: (A) control group showing the normal histological structure of islets of Langerhans with normal pancreatic acini; (B) diabetic group showing ruptured and destroyed islets of Langerhans with damage in beta cells; and (C,D) Rp-Nc 0.5 mg- and 1 mg-treated groups showing some normal islets of Langerhans with some mild destruction in normal pancreatic ducts and in between normal pancreatic acini (H&E scale bar, 25 µm).